{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-015753","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.448542+00:00","generated_at":"2026-06-05T22:12:35.141668+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Unicycive regains compliance with Nasdaq minimum market value and bid price rules","bullets":["On Feb 21, 2024, Nasdaq notified Unicycive that it regained compliance with the $35M minimum market value and $1.00 minimum bid price requirements.","Non-compliance notices were originally received on Sept 19, 2023, for both Nasdaq Listing Rules 5550(b)(2) and 5550(a)(2).","The compliance matters are now closed with no further action required."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-015753","json":"https://secwatch.observer/filing/0001213900-24-015753.json","markdown":"https://secwatch.observer/filing/0001213900-24-015753.md","text":"https://secwatch.observer/filing/0001213900-24-015753.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/0001213900-24-015753-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/ea0200428-8k_unicyc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T22:12:35.141668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}